The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

[1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in all immunization programs implemented by nations. Indeed, the introduction of HBV vaccination in Europe ...

Now, the company has substantial funding to continue advancing what executives hope represents a new treatment option, and potential cure, for hepatitis B. The company's Series B round includes ...

Background: The duration of protection after hepatitis B vaccination of infants is unknown. Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 ...

The epigenetic silencing drug for chronic hepatitis B (HBV ... As well as Tune-401, some of the series B cash will “also support the development of additional gene, cell, and regenerative ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

Series A and B are the two major funding rounds startups conduct to raise capital, typically following a seed round. Jantz said his company picked chronic hepatitis B for its first trial because ...